Skip to content

Clinical trials

Epilepsy trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: Japan Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20094
20105
20118
20123
20131
20143
20153
20164
20173
20183
20193
20201
20212
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Active, not recruiting3
Recruiting3
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Japan Co. Ltd.9
Eisai Co., Ltd.6
GlaxoSmithKline4
UCB BIOSCIENCES, Inc.4
UCB Biopharma SRL4
Longboard Pharmaceuticals3
UCB Biopharma S.P.R.L.3
Eli Lilly and Company2
UCB BIOSCIENCES GmbH2
UCB Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy50
Seizures21
Drug Resistant Epilepsy4
Epilepsies, Myoclonic4
Lennox Gastaut Syndrome4
Neurodevelopmental Disorders3
Brain Diseases2
Neuroblastoma1
Small Cell Lung Carcinoma1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.